Detailed Information on Publication Record
2004
17beta Hydroxysteroid Dehydrogenase Type 3 Inhibitors
PARUCH, Kamil and Timothy GUZIBasic information
Original name
17beta Hydroxysteroid Dehydrogenase Type 3 Inhibitors
Name in Czech
17beta Hydroxysteroid Dehydrogenase Type 3 Inhibitors
Authors
PARUCH, Kamil (203 Czech Republic, guarantor) and Timothy GUZI (840 United States of America)
Edition
Number: WO 2004/046111 A1, Publisher: World Intellectual Property Organization, Place of publication: USA, Owner's name: Schering-Plough, 2004
Other information
Language
English
Type of outcome
Patent
Field of Study
10401 Organic chemistry
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
RIV identification code
RIV/00216224:14310/04:00036032
Organization unit
Faculty of Science
Keywords (in Czech)
hydroxysteroid dehydrogenase; inhibitor; prostate cancer
Keywords in English
hydroxysteroid dehydrogenase; inhibitor; prostate cancer
Změněno: 25/6/2009 14:45, doc. Mgr. Kamil Paruch, Ph.D.
V originále
The invention relates to a prepn. of piperazine derivs. of formula I [wherein: X is CH or N; Z is O or NH, N-alkyl, or N-aryl, etc.; R1 and R2 are independently selected from (un)substituted (hetero)aryl, (hetero)arylalkyl; R3 is H, OH, alkoxy, aryloxy, etc.; R4 is H, (cyclo)alkyl, (hetero)aryl, etc.; R5 is C(O)R6 or SO2R6; R6 is alkyl, (hetero)aryl, (hetero)arylalkyl, (un)substituted amine], useful as inhibitors of type 3 17.beta.-hydroxysteroid dehydrogenase. The invention compds. are claimed to be useful for the treatment, prevention, inhibition, or amelioration of diseases such as prostate cancer, acne, and androgenic alopecia, etc. The invention compds. exhibited a range of 17.beta.-hydroxysteroid dehydrogenase type 3 binding activity from about 0.005 nM to 10 nM. For instance, piperazine deriv. II was prepd. via amination of phenyl(trifluoromethylphenyl)methanol by (S)-2-tert-butylpiperazine (example 7) and subsequent reaction of the obtained piperazine deriv. III and piperidine deriv. IV (example 15).
In Czech
viz Anotace